Showing results (1-10 of 320) with videos related to
Sort By:
Pageof 32
Biopharmaceutics & Drug Disposition|January 1, 1983
Human platelet response to three salicylate dosage formsJ J Thiessen, H Grad, S M Macleod, et al.Clinical Pharmacology and Therapeutics|September 1, 1988
Cystic fibrosis: enhanced theophylline metabolism may be linked to the diseaseD C Knoppert, M Spino, R Beck, et al.The Journal of Pediatrics|November 1, 1984
Cloxacillin absorption and disposition in cystic fibrosisM Spino, R P Chai, A F Isles, et al.Pharmaceutical Research|January 3, 2006
Transport kinetics of iron chelators and their chelates in Caco-2 cellsXi-Ping Huang, M Spino, J J ThiessenThe Journal of Pediatrics|July 1, 1985
Assessment of glomerular filtration rate and effective renal plasma flow in cystic fibrosisM Spino, R P Chai, A F Isles, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|March 10, 2001
High-performance liquid chromatographic assays for a second-generation novel oral iron chelator (APCP363) and their application to pharmacokinetic studies in ratsF Guo, J J Thiessen, A Tesoro, et al.Journal of Pharmaceutical Sciences|August 1, 1982
High-pressure liquid chromatographic assay of cloxacillin in serum and urineF W Teare, R H Kwan, M Spino, et al.Journal of Pharmaceutical Sciences|October 1, 1982
High-pressure liquid chromatographic assays for ticarcillin in serum and urineR H Kwan, S M MacLeod, M Spino, et al.Antimicrobial Agents and Chemotherapy|November 1, 1983
High-pressure liquid chromatographic analysis of ceftazidime in serum and urineJ S Leeder, M Spino, A M Tesoro, et al.Canadian Medical Association Journal|June 24, 1978
Adverse biochemical and clinical consequences of furosemide administrationM Spino, E M Sellers, H L Kaplan, et al.Pageof 32